One of the things that Kev spoke about in episode 3 is engaging people who use drugs in research. Kev chatted about his own research enquiry and reflected on this more broadly within the field too. Listen to the latest episode to find out more!
Happy 2024 to all our followers. A bit of a slower start to social media this year after returning to the UK from Australia.
If you need some Monday Inspo, why not listen the latest podcast episode with @KevDertadian which includes a discussion on drug consumption rooms!
In episode 3, we discuss @KevDertadian research on the non medical use of prescription drugs. This helps us expand the conceptualisation and meaning of drug use in contemporary societies. Tune in to find out more!
We are GO! I had the great pleasure of chatting to @KevDertadian for ep 3 Kev is an advocate for centralising the voices of people who use drugs in research and critically interrogating policy, discourses and practices that surround marginalised groups. ENJOY โ๏ธ
Have you listened to episode 2 yet? We chatted about the sites of participation in drug policy debates and processes. Here, @AlisonRitter1 reminds us to think carefully about the environments in which participation takes place! Episode 3 coming your way soon ๐
In episode 2, we talk about what counts as evidence in drug policy. This goes beyond traditional reports and clinical trials and asks us to think more creatively about evidence in the drug policy context.
In episode 2, we discussed the need to think creatively about what โevidenceโ can be in drug policy ๐ก Listen via our website or your usual podcast provider.
In episode 2, we chatted about who the experts are in drug policy. This opened up a discussion about lived experience as expertise. Who are the experts in drug policy? Have a listen to the episode and let us know what you think in the comments!
@ISSDrugPolicy @AlisonRitter1 @kari_lancaster @drskew@ISSDrugPolicy conference is where we all first met and connected. ISSDP is such an important place for research knowledge and exchange within our community ๐
Episode 2, Season 2. Two excellent guests talking about some of their paradigm shifting research. @AlisonRitter1 and @kari_lancaster in conversation about evidence and expertise in drug policy. Itโs a gudden! ๐
Our last episode featured here and available to listen via major podcast platforms. Check out @HRInews for their recent divest invest report โ๏ธโค๏ธ๐งก๐๐๐๐
We spend 750x more on punitive responses to drugs than we do on life-saving services for people who use drugs. What could we achieve if we divest from the drug war? #investinjustice
Our Executive Director @NaomiSBS on @DPVoices: https://t.co/gsxhE9Nzms
We will be launching the next episode of our podcast on Thursday. Details coming soon.
If thatโs too long to wait then have a listen to our previous episodes. Our last episode was about global harm reduction, where we had a number of excellent guests. โค๏ธโ๐ฉน๐
Episode 1 of Season 2 is all about Global Harm Reduction. Our guests were from Australia, UK, Thailand, Indonesia and Latin America. Have a listen to hear what the most pressing harm reduction needs in their regions. โค๏ธโ๐ฉนโค๏ธโ๐ฉนโค๏ธโ๐ฉนโค๏ธโ๐ฉนโค๏ธโ๐ฉนโค๏ธโ๐ฉน @HRInews @CAHMA__ @aivl@wearenapud@INPUD
Have you listened to our latest podcast episode yet? It was recorded at @harmreductionintl conference in April. A key theme throughout the conference was about prioritising the dignity, respect and rights of People who use drugs. @wearenapud@INPUD@aivl @CAHMA__
@drskew on the role of values in drug policy from @DrugPolicyVoic1 project data. Getting at peopleโs values is key to understand orientations and attitudes towards drugs and drug policy #ISSDP2023